Summary
On June 23, 2015, Cardinal Health, Inc. (CAH) announced the successful issuance and sale of a significant debt offering totaling $1.5 billion. This offering comprised three tranches of notes: $550 million in 1.950% notes due 2018, $500 million in 3.750% notes due 2025, and $450 million in 4.900% notes due 2045. The issuance was conducted under an effective registration statement on Form S-3 and involved a syndicate of underwriters led by Goldman, Sachs & Co., Barclays Capital Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, and Mitsubishi UFJ Securities (USA), Inc. This debt issuance provides Cardinal Health with substantial capital, likely to fund ongoing operations, potential acquisitions, or further strategic initiatives. The varying maturities and interest rates suggest a diversified approach to debt management, aiming to balance cost of capital with flexibility for future financial planning. Investors can view this as a signal of the company's continued access to capital markets and its proactive approach to managing its balance sheet.
Key Highlights
- 1Cardinal Health, Inc. (CAH) successfully issued and sold $1.5 billion in aggregate principal amount of senior notes.
- 2The offering consisted of three tranches: $550 million of 1.950% notes due 2018, $500 million of 3.750% notes due 2025, and $450 million of 4.900% notes due 2045.
- 3The issuance occurred on June 23, 2015, and was made pursuant to an effective registration statement on Form S-3.
- 4A syndicate of underwriters, including major financial institutions like Goldman Sachs, Barclays Capital, and Merrill Lynch, facilitated the offering.
- 5The proceeds from this debt issuance are expected to provide the company with significant liquidity for various corporate purposes.
- 6Legal opinions regarding the legality of the notes were provided by the company's Senior Vice President and Associate General Counsel and external counsel Gibson, Dunn & Crutcher LLP.